Navigation Links
Testosterone patch for women Rejected For safety Reasons

The experimental testosterone patch used for treating women with sexual difficulties was rejected by a panel of advisors to the US Food// and Drug Administration recently .

Procter & Gamble, global manufacturer of household products, wants to market the patch to women who have become menopausal after ovarian surgery however due to the rejection by members of the FDA panel the drug is kept on hold until more data is available to assess the drug.

At a recent meeting panel members strongly criticized the company funded clinical trials as "inadequate" to assess issues of long term safety. Panel members also raised serious concerns about the risks of cardiovascular disease and breast cancer associated with a drug that appeared to offer women, on average, little more than one extra episode of sexual activity a month, compared with placebo.

Panel members also say that don't want to expose several million American women to the risk of myocardial infarction and stroke, with such devastating consequences, in order that they can have one more sexual episode a month .

So far no data has been published by Procter & Gamble's after their 24 week randomised controlled trials of the patch . Abstracts presented at conferences have claimed repeatedly that the drug is safe and effective and has side effects similar to those of placebo. Yet data presented at last week's FDA meeting showed that women using testosterone were more likely to experience hair growth, acne, and weight gain.

Procter & Gamble's officials and the company's paid academic consultants have been questioned by the FDA about the clinical meaningfulness of the drug's small benefits, the lack of long term data, and the scientific uncertainties that surround the link between testosterone concentrations and sexual difficulties. Procter & Gamble has also agreed it will work with the FDA and try to provide additional safety data before the launch of the drug in the market.
'"/>




Page: 1 2

Related medicine news :

1. Testosterone Replacement Therapy Safe If Monitored Appropriately
2. Low Testosterone Levels the Cause Of Depression In Men
3. The Use Of Testosterone Replacement Therapy Questioned
4. Depression In Men Could Be To Low Testosterone Levels
5. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
6. Testosterone Therapy can improve sexual function in postmenopausal women
7. Fatherhood Found To Tame Men by Reducing Testosterone Levels
8. Testosterone levels could serve as a marker for determining risk of SIDS
9. Males Lifespan Shortened By Elevated Levels Of Testosterone
10. Study Indicates An Increased Risk Of Breast Cancer In Women Undertaking Estrogen and Testosterone Therapy
11. Low Testosterone Linked With Early Death

Post Your Comments:
(Date:11/30/2009)...surprised and dismayed by the Grand Jury,s True Bi... and my career as an attorney, a juvenile court ju... Youth Commission, I have upheld the spirit and th...o the protection, prevention and rehabilitation of... Of the many concerns that people have communicate...
(Date:11/30/2009)...han sedentary, healthy adults , , , MON...n that exercise can help ward off heart disease an...on why may be found within cells themselves. , ,...t the tips of chromosomes that protect the cell --...ng adults who did not exercise regularly, German r...
(Date:11/30/2009)...nline and mobile tool empowers patients to be acti...,, ARLINGTON, Va., Nov. 30 /PRNewswire-USNews...IDS resource online, today launched My Health Trac...nfected patients the ability to save, track and an...ponsorship from Merck, is available at www.thebod...
(Date:11/30/2009).../ -- Harrington Physician Services (HPS) is please...icians Martin Devine, Leah Doret, Elizabeth Fuller..., These four esteemed and popular Charlton-based ...on join the Harrington family in the new Harringto...nder construction at 10 North Main Street, at the ...
(Date:11/30/2009)...re/ -- The launch of Invivo Corporation,s ONCAD fo...cleared, fully-automated morphological system for ...picious breast lesions. The ONCAD system will be o...North America 2009 Annual Meeting in Chicago. ,... breast MRI, ONCAD for DynaCAD uses a patented mat...
Breaking Medicine News(10 mins):Health News:Independent Ombudsman for Texas Youth Commission Resigns 2Health News:Exercise Guards White Blood Cells Against Aging 2Health News:Exercise Guards White Blood Cells Against Aging 3Health News:TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 2Health News:Family Practice Physicians Martin Devine, Leah Doret, Elizabeth Fuller and Monika Mathur Join Harrington Physician Services in Charlton 3Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3
...ne phosphatase levels boosted mortality 25% in chr...ealthDay News) -- High levels of alkaline phosphat... -- may signal an increased risk of death among pa...three-year period. It found that patients with alk...
... DRIVEN BY SUCCESSFUL U.S. COMMERCIAL LAUNCH OF HE...ANSPLANTATION, PLEASANTON, Calif., July 31 Thora...n device-based mechanical,circulatory support ther...me period a year ago., Revenues for the quarter e...
...R, Mich. Pat Phalin learned she had hearing loss ...at her local school. The pupils heard sounds she c...enthusiast, saw a pattern in his wife,s family his...ched school age. , The hearing loss must be here...
... Ala., July 31 HealthSouth,Corporation (NYSE: HL...,subsidiaries, its previously announced purchase o...4-bed inpatient rehabilitation hospital in,Vinelan...ip of Dr. Francis Bonner, has provided exceptional...
...FL (July 31, 2008) -- The National Institutes of H...f South Florida research team led by Jeffrey Krisc...revention and treatment of juvenile diabetes. This...ard adds to the $169 million received last year by...
...upport nonprofits in Portland and Seattle that imp...ity, PORTLAND, Ore., July 31 The Regence Foundat... for organizations working to,improve health care ...ctices that promote positive transformation of,the...
Other Medicine News:Health News:Bone Disease Test Shows Death Risk for Dialysis Patients 2Health News:Thoratec Reports 44 Percent Increase in Second Quarter Revenues; 2Health News:Thoratec Reports 44 Percent Increase in Second Quarter Revenues; 3Health News:Thoratec Reports 44 Percent Increase in Second Quarter Revenues; 4Health News:Thoratec Reports 44 Percent Increase in Second Quarter Revenues; 5Health News:Thoratec Reports 44 Percent Increase in Second Quarter Revenues; 6Health News:Thoratec Reports 44 Percent Increase in Second Quarter Revenues; 7Health News:Thoratec Reports 44 Percent Increase in Second Quarter Revenues; 8Health News:Thoratec Reports 44 Percent Increase in Second Quarter Revenues; 9Health News:Thoratec Reports 44 Percent Increase in Second Quarter Revenues; 10Health News:Thoratec Reports 44 Percent Increase in Second Quarter Revenues; 11Health News:Thoratec Reports 44 Percent Increase in Second Quarter Revenues; 12Health News:Thoratec Reports 44 Percent Increase in Second Quarter Revenues; 13Health News:Thoratec Reports 44 Percent Increase in Second Quarter Revenues; 14Health News:Thoratec Reports 44 Percent Increase in Second Quarter Revenues; 15Health News:Inherited form of hearing loss stems from gene mutation 2Health News:Inherited form of hearing loss stems from gene mutation 3Health News:HealthSouth Finalizes Purchase of New Jersey Rehabilitation Hospital 2Health News:HealthSouth Finalizes Purchase of New Jersey Rehabilitation Hospital 3Health News:University of South Florida receives new multimillion award to assess juvenile diabetes treatments 2Health News:University of South Florida receives new multimillion award to assess juvenile diabetes treatments 3Health News:Regence Foundation Announces Three Grants Totaling $195,000 2
(Date:11/30/2009)..., , TORONTO, Nov. 30 The Spec...Inc. ("Patheon" or the "Company") (TSX: PTI) and J...oldings, LLC (collectively, "JLL"), today announce...tlement agreement in respect of the pending legal ...t provides among other things that: ,, until M...
(Date:11/30/2009)..., , MELVILLE, N.Y., Nov. 30 /PRNewswire-Fir...he largest provider of health care products and se...Company,s Executive Vice President and Chief Finan...Investor Program on Tuesday, December 1, 2009. Th...in London. ,, Henry Schein,s presentation is s...
(Date:11/30/2009)..., , MT. LAUREL, N.J., Nov. 30 /PRNewswire-Fi...ing provider of technology-enabled clinical docume...ed an agreement with Nuance Communications, Inc. (...ce,s SpeechMagic speech recognition engine and pro...icine(TM), MedQuist,s front-end speech recognition...
Breaking Medicine Technology:Patheon and JLL Partners Announce Litigation Settlement 2Patheon and JLL Partners Announce Litigation Settlement 3Henry Schein to Present at the NASDAQ OMX 23rd Investor Program 2MedQuist Signs Agreement Extending Use of Real-Time Speech Recognition Engine to Wide Range of Medical Specialties 2California Health Insurance Assistance Program Awarded 2009 Grant Funding Says MedicareSupplementPlans com 52178 1California Health Insurance Assistance Program Awarded 2009 Grant Funding Says MedicareSupplementPlans com 52178 2FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 1FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 2FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 3FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 4FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 5FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 6FDA Approves Tekturna HCT 28R 29 as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent 4755 7ISSA Announces New Specialist in Fitness Nutrition Certification 52175 1ISSA Announces New Specialist in Fitness Nutrition Certification 52175 2
...x Labs, Inc. (OTC,Bulletin Board: GOVX), an Atlant...ay announced its financial results and provided an...r 30, 2007. Financial Results for the Quarter End...loss of $1,165,509 for the three months,ended Sept...period in 2006.,For the nine months ended Septembe...
...RISBANE, Calif., Nov. 15 BiPar,Sciences, Inc., a ...g novel,cancer therapies, today announced it has i...r, BSI-201, in patients with triple-negative breas...erone or HER2 receptors. The company designed the... a major unmet medical need-based on molecular bio...
Other Medicine Technology:GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 2GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 3GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 4GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 5GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 6GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 7GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 8GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 9GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update 10BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data 2BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data 3
Vertebral Body Replacement (VBR)
Vertigraft Femoral Shaft
...ackable cage system provides anterior column suppo...vertebrectomies from T1 to L5. The system consists...at are stacked to a desired height, accommodating ...orced polymer material emulates the biomechanical ...
... bone void filler is an extrudable, moldable bone ...se anywhere in the skeletal system, including extr...sorbable, serving as a temporary scaffolding for n...visible on X-ray, making healing easier to assess....
Medicine Products: